Matches in Wikidata for { <http://www.wikidata.org/entity/Q64694264> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q64694264 description "clinical trial" @default.
- Q64694264 description "ensayu clínicu" @default.
- Q64694264 description "klinisch onderzoek" @default.
- Q64694264 description "клінічне випробування" @default.
- Q64694264 description "կլինիկական փորձարկում" @default.
- Q64694264 name "Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment" @default.
- Q64694264 type Item @default.
- Q64694264 label "Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment" @default.
- Q64694264 prefLabel "Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment" @default.
- Q64694264 P1132 Q64694264-F4B1CA42-872A-4568-AFF5-A87639F32B2B @default.
- Q64694264 P131 Q64694264-0920C9C2-0D5B-4B30-ACE8-CC1911EF22F4 @default.
- Q64694264 P131 Q64694264-5F23FE24-B8E8-4126-8371-FC53040242BB @default.
- Q64694264 P1476 Q64694264-B0C14971-5CC4-4BAF-9085-7DD648F09681 @default.
- Q64694264 P17 Q64694264-14447BE2-0714-4F48-90E1-492B9F46C48E @default.
- Q64694264 P17 Q64694264-1C5858BA-08AC-408C-BDAD-22482BE6558C @default.
- Q64694264 P17 Q64694264-3DAE7882-8CEC-4A61-AA87-479A7B584288 @default.
- Q64694264 P17 Q64694264-40FF42CC-AB89-4EE0-A02F-DB80D0AAA117 @default.
- Q64694264 P17 Q64694264-45656DDC-B444-4045-B314-2805B81168B2 @default.
- Q64694264 P17 Q64694264-47766F98-99DA-4EAC-9069-E37B06F105CF @default.
- Q64694264 P17 Q64694264-4A58B3CC-EFBD-4A4A-98DE-0FC096311091 @default.
- Q64694264 P17 Q64694264-54440A19-302A-4A8F-9B2F-55A88AC79224 @default.
- Q64694264 P17 Q64694264-5C48B7F9-1987-4ABA-8FBA-28407FFA00AA @default.
- Q64694264 P17 Q64694264-7DA150B2-7864-4569-B683-F8FBB10D3BC6 @default.
- Q64694264 P17 Q64694264-BC8CFF9C-37BD-48D0-BBE5-22CC97797010 @default.
- Q64694264 P17 Q64694264-C4CD3340-D330-43C2-AE8D-3C91F667CE30 @default.
- Q64694264 P17 Q64694264-D776FC20-37AB-44A4-ABD3-1DA7E865CC7E @default.
- Q64694264 P17 Q64694264-E685032F-8CE3-47A4-A434-1E08147EF31E @default.
- Q64694264 P1813 Q64694264-3E780385-6410-48BF-AF39-357678779EC2 @default.
- Q64694264 P2899 Q64694264-AAE7F6CB-DFB7-4DF6-8BC9-E07B7F5EC332 @default.
- Q64694264 P3098 Q64694264-5D87EE0D-AE23-4F56-9BD8-E223F145EC70 @default.
- Q64694264 P31 Q64694264-51008531-B547-43D0-8469-606EB0A14A3D @default.
- Q64694264 P580 Q64694264-0C15B1BD-06FC-4511-A010-1A1256D9618B @default.
- Q64694264 P582 Q64694264-FF86DEA7-3EA6-4FC8-A27F-40FBC912F0F4 @default.
- Q64694264 P6099 Q64694264-43F6A39E-BCF6-4A39-A345-BF7D543E03A0 @default.
- Q64694264 P6153 Q64694264-332928F7-2434-4E03-8E5A-D6EBFD53C114 @default.
- Q64694264 P6153 Q64694264-97E79F27-2F81-4FF1-9961-356CECD5DF7A @default.
- Q64694264 P6153 Q64694264-B38077EA-A858-41B1-89C3-D268A7F9401D @default.
- Q64694264 P6153 Q64694264-CC8D8405-F70B-41C6-B126-745F5FD899EC @default.
- Q64694264 P6153 Q64694264-CCE93EE6-740A-42A7-8D68-222FF358AF01 @default.
- Q64694264 P6153 Q64694264-F205EC0C-DC3C-404D-AAE3-586A08DC2681 @default.
- Q64694264 P8363 Q64694264-B04D1846-49F6-4102-B78B-34F682218F5B @default.
- Q64694264 P859 Q64694264-AE4DA3DC-2233-4966-B3A7-B5A8D755A94C @default.
- Q64694264 P1132 "+587" @default.
- Q64694264 P131 Q1183 @default.
- Q64694264 P131 Q8646 @default.
- Q64694264 P1476 "A Randomized, Double-blind, Multi-center Phase III Study of Brivanib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed or Are Intolerant to Sorafenib: The BRISK PS Study (Brivanib Study in HCC Patients at Risk Post Sorafenib)" @default.
- Q64694264 P17 Q142 @default.
- Q64694264 P17 Q155 @default.
- Q64694264 P17 Q16 @default.
- Q64694264 P17 Q17 @default.
- Q64694264 P17 Q183 @default.
- Q64694264 P17 Q29 @default.
- Q64694264 P17 Q30 @default.
- Q64694264 P17 Q31 @default.
- Q64694264 P17 Q38 @default.
- Q64694264 P17 Q41 @default.
- Q64694264 P17 Q414 @default.
- Q64694264 P17 Q668 @default.
- Q64694264 P17 Q865 @default.
- Q64694264 P17 Q96 @default.
- Q64694264 P1813 "BRISK PS" @default.
- Q64694264 P2899 "+18" @default.
- Q64694264 P3098 "NCT00825955" @default.
- Q64694264 P31 Q30612 @default.
- Q64694264 P580 "2009-02-17T00:00:00Z" @default.
- Q64694264 P582 "2011-11-15T00:00:00Z" @default.
- Q64694264 P6099 Q42824827 @default.
- Q64694264 P6153 Q1057447 @default.
- Q64694264 P6153 Q1130172 @default.
- Q64694264 P6153 Q1950740 @default.
- Q64694264 P6153 Q2415975 @default.
- Q64694264 P6153 Q309331 @default.
- Q64694264 P6153 Q49117 @default.
- Q64694264 P8363 Q78089383 @default.
- Q64694264 P859 Q266423 @default.